on December 29, 2003
Arteriosclerosis, Thrombosis, and Vascular Biology. 2003
Published online before print December 29, 2003, doi: 10.1161/01.ATV.0000114567.76772.33
Published online before print December 29, 2003, doi: 10.1161/01.ATV.0000114567.76772.33
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 9, 2003
Accepted on July 30, 2003
Transforming Growth Factor 
and Atherosclerosis: So Far, So Good for the Protective Cytokine Hypothesis
David J. Grainger *
From the Department of Medicine, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK.
* To whom correspondence should be addressed. E-mail: djg15{at}cam.ac.uk.
Abstract--The role of the anti-inflammatory cytokine transforming growth factor 
(TGF-) in atherosclerosis has been the subject of considerable debate for a decade. In the early 1990s, we postulated that TGF- played an important role in maintaining normal vessel wall structure and that loss of this protective effect contributed to the development of atherosclerosis. We termed this the protective cytokine hypothesis. This proposal was slow to gain broad acceptance, however, because at that time there were little data available on the role of TGF- during the development of atherosclerosis but much information about its role during trauma-induced neointima formation. Because TGF- apparently aggravates neointima formation, both by inhibiting endothelial regeneration and by promoting fibrosis, it was difficult to accept that its presence might ameliorate the superficially similar atherogenesis process. But several recent studies revealed beyond doubt the fact that TGF- protects against lipid lesion formation, at least in mouse models of atherosclerosis. Therefore, two important questions remain. First, is the role of TGF- in vascular biology similar in humans and in mice? Secondly, how important, compared with defects in thrombosis or lipoprotein metabolism, is the protective role of TGF- during atherogenesis?
Key words: TGF-
•
myocardial infarction •
inflammation
This article has been cited by other articles:
 |
|
 |
|
  A. D. Frutkin, G. Otsuka, A. Stempien-Otero, C. Sesti, L. Du, M. Jaffe, H. L. Dichek, C. J. Pennington, D. R. Edwards, M. Nieves-Cintron, et al. TGF-{beta}1 Limits Plaque Growth, Stabilizes Plaque Structure, and Prevents Aortic Dilation in Apolipoprotein E-Null Mice Arterioscler Thromb Vasc Biol, September 1, 2009; 29(9): 1251 - 1257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Kim, M. Y. Kim, H. Jin, H. J. Kim, S. S. Kang, H. J. Kim, J. H. Lee, K. C. Chang, J.-Y. Hwang, C. Yabe-Nishimura, et al. Peroxisome Proliferator-Activated Receptor {delta} Regulates Extracellular Matrix and Apoptosis of Vascular Smooth Muscle Cells Through the Activation of Transforming Growth Factor-{beta}1/Smad3 Circ. Res., July 2, 2009; 105(1): 16 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Dell'Omo, G. Penno, L. Pucci, D. Lucchesi, S. Del Prato, and R. Pedrinelli Lack of association between TGF-{beta}-1 genotypes and microalbuminuria in essential hypertensive men Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1864 - 1869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hara, A. Shiga, T. Fukutake, H. Nozaki, A. Miyashita, A. Yokoseki, H. Kawata, A. Koyama, K. Arima, T. Takahashi, et al. Association of HTRA1 Mutations and Familial Ischemic Cerebral Small-Vessel Disease N. Engl. J. Med., April 23, 2009; 360(17): 1729 - 1739. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. T.G. Bot, I. E. Hoefer, J. P.G. Sluijter, P. van Vliet, A. M. Smits, F. Lebrin, F. Moll, J.-P. de Vries, P. Doevendans, J. J. Piek, et al. Increased Expression of the Transforming Growth Factor-{beta} Signaling Pathway, Endoglin, and Early Growth Response-1 in Stable Plaques Stroke, February 1, 2009; 40(2): 439 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. F. Panoulas, K. M. J. Douglas, J. P. Smith, A. Stavropoulos-Kalinoglou, G. S. Metsios, P. Nightingale, and G. D. Kitas Transforming growth factor-{beta}1 869T/C, but not interleukin-6 -174G/C, polymorphism associates with hypertension in rheumatoid arthritis Rheumatology, February 1, 2009; 48(2): 113 - 118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Y. Liu, H. F. Peng, and S. T. Andreadis Contractile smooth muscle cells derived from hair-follicle stem cells Cardiovasc Res, July 1, 2008; 79(1): 24 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gratchev, J. Kzhyshkowska, S. Kannookadan, M. Ochsenreiter, A. Popova, X. Yu, S. Mamidi, E. Stonehouse-Usselmann, I. Muller-Molinet, L. Gooi, et al. Activation of a TGF-{beta}-Specific Multistep Gene Expression Program in Mature Macrophages Requires Glucocorticoid-Mediated Surface Expression of TGF-{beta} Receptor II J. Immunol., May 15, 2008; 180(10): 6553 - 6565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Kim, S. A. Ham, S. U. Kim, J.-Y. Hwang, J.-H. Kim, K. C. Chang, C. Yabe-Nishimura, J.-H. Kim, and H. G. Seo Transforming Growth Factor-{beta}1 Is a Molecular Target for the Peroxisome Proliferator-Activated Receptor {delta} Circ. Res., February 1, 2008; 102(2): 193 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Lagna, M. M. Ku, P. H. Nguyen, N. A. Neuman, B. N. Davis, and A. Hata Control of Phenotypic Plasticity of Smooth Muscle Cells by Bone Morphogenetic Protein Signaling through the Myocardin-related Transcription Factors J. Biol. Chem., December 21, 2007; 282(51): 37244 - 37255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Korff, K. Aufgebauer, and M. Hecker Cyclic Stretch Controls the Expression of CD40 in Endothelial Cells by Changing Their Transforming Growth Factor-{beta}1 Response Circulation, November 13, 2007; 116(20): 2288 - 2297. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.R.S. Girn, N.M. Orsi, and S. Homer-Vanniasinkam An overview of cytokine interactions in atherosclerosis and implications for peripheral arterial disease Vascular Medicine, November 1, 2007; 12(4): 299 - 309. [Abstract] [PDF]
|
|
|
|
 |
|
 C.-L. Chen, I-H. Liu, S. J. Fliesler, X. Han, S. S. Huang, and J. S. Huang Cholesterol suppresses cellular TGF-beta responsiveness: implications in atherogenesis J. Cell Sci., October 15, 2007; 120(20): 3509 - 3521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. S. Chatzizisis, A. U. Coskun, M. Jonas, E. R. Edelman, C. L. Feldman, and P. H. Stone Role of Endothelial Shear Stress in the Natural History of Coronary Atherosclerosis and Vascular Remodeling: Molecular, Cellular, and Vascular Behavior J. Am. Coll. Cardiol., June 26, 2007; 49(25): 2379 - 2393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Naumnik, J. Borawski, K. Pawlak, and M. Mysliwiec Enoxaparin but not unfractionated heparin causes a dose-dependent increase in plasma TGF-{beta}1 during haemodialysis: a cross-over study Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1690 - 1696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. P. Fay, N. Garg, and M. Sunkar Vascular Functions of the Plasminogen Activation System Arterioscler Thromb Vasc Biol, June 1, 2007; 27(6): 1231 - 1237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ruiz-Ortega, J. Rodriguez-Vita, E. Sanchez-Lopez, G. Carvajal, and J. Egido TGF-{beta} signaling in vascular fibrosis Cardiovasc Res, May 1, 2007; 74(2): 196 - 206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Grainger TGF-{beta} and atherosclerosis in man Cardiovasc Res, May 1, 2007; 74(2): 213 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Boon, J. O. Fledderus, O. L. Volger, E. J.A. van Wanrooij, E. Pardali, F. Weesie, J. Kuiper, H. Pannekoek, P. ten Dijke, and A. J.G. Horrevoets KLF2 Suppresses TGF-{beta} Signaling in Endothelium Through Induction of Smad7 and Inhibition of AP-1 Arterioscler Thromb Vasc Biol, March 1, 2007; 27(3): 532 - 539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lazo-Langner, G. A. Knoll, P. S. Wells, N. Carson, and M. A. Rodger The risk of dialysis access thrombosis is related to the transforming growth factor-beta1 production haplotype and is modified by polymorphisms in the plasminogen activator inhibitor-type 1 gene Blood, December 15, 2006; 108(13): 4052 - 4058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-K. L. Robertson and G. K Hansson T Cells in Atherogenesis: For Better or For Worse? Arterioscler Thromb Vasc Biol, November 1, 2006; 26(11): 2421 - 2432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Gozdzikiewicz, J. Borawski, B. Naumnik, A. Rydzewska-Rosolowska, K. Pawlak, and M. Mysliwiec TGF-{beta}1 and Endothelial/Tissue Injury With High-dose Intravenous Iron Therapy in Renal Failure: Evidence or Perception? Clinical and Applied Thrombosis/Hemostasis, October 1, 2006; 12(4): 493 - 494. [PDF]
|
|
|
|
|
|
N. N. Singh and D. P. Ramji Transforming Growth Factor-{beta}-Induced Expression of the Apolipoprotein E Gene Requires c-Jun N-Terminal Kinase, p38 Kinase, and Casein Kinase 2 Arterioscler Thromb Vasc Biol, June 1, 2006; 26(6): 1323 - 1329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Koch, P. Hoppmann, J. C. Mueller, A. Schomig, and A. Kastrati Association of Transforming Growth Factor-{beta}1 Gene Polymorphisms With Myocardial Infarction in Patients With Angiographically Proven Coronary Heart Disease Arterioscler Thromb Vasc Biol, May 1, 2006; 26(5): 1114 - 1119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tedgui and Z. Mallat Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways Physiol Rev, April 1, 2006; 86(2): 515 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ruiz-Ortega, M. Ruperez, V. Esteban, J. Rodriguez-Vita, E. Sanchez-Lopez, G. Carvajal, and J. Egido Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases Nephrol. Dial. Transplant., January 1, 2006; 21(1): 16 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Seay, D. Sedding, S. Krick, M. Hecker, W. Seeger, and O. Eickelberg Transforming Growth Factor-{beta}-Dependent Growth Inhibition in Primary Vascular Smooth Muscle Cells Is p38-Dependent J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1005 - 1012. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Baraldo, E Bazzan, G Turato, F Calabrese, B Beghe, A Papi, P Maestrelli, L M Fabbri, R Zuin, and M Saetta Decreased expression of TGF-{beta} type II receptor in bronchial glands of smokers with COPD Thorax, December 1, 2005; 60(12): 998 - 1002. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. F.H. Lai, D. W. Courtman, and D. J. Stewart NO to Small Mothers Against Decapentaplegic (Smad) Circ. Res., November 25, 2005; 97(11): 1087 - 1089. [Full Text] [PDF]
|
|
|
|
|
|
D. J. Grainger and P. M. Schofield Tamoxifen for the Prevention of Myocardial Infarction in Humans: Preclinical and Early Clinical Evidence Circulation, November 8, 2005; 112(19): 3018 - 3024. [Full Text] [PDF]
|
|
|
|
 |
|
 K.-G. Shyu, Y.-M. Chao, B.-W. Wang, and P. Kuan Regulation of Discoidin Domain Receptor 2 by Cyclic Mechanical Stretch in Cultured Rat Vascular Smooth Muscle Cells Hypertension, September 1, 2005; 46(3): 614 - 621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rodriguez-Vita, M. Ruiz-Ortega, M. Ruperez, V. Esteban, E. Sanchez-Lopez, J. J. Plaza, and J. Egido Endothelin-1, via ETA Receptor and Independently of Transforming Growth Factor-{beta}, Increases the Connective Tissue Growth Factor in Vascular Smooth Muscle Cells Circ. Res., July 22, 2005; 97(2): 125 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Norata, E. Callegari, M. Marchesi, G. Chiesa, P. Eriksson, and A. L. Catapano High-Density Lipoproteins Induce Transforming Growth Factor-{beta}2 Expression in Endothelial Cells Circulation, May 31, 2005; 111(21): 2805 - 2811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Okada, G. Takemura, K.-i. Kosai, Y. Li, T. Takahashi, M. Esaki, K. Yuge, S. Miyata, R. Maruyama, A. Mikami, et al. Postinfarction Gene Therapy Against Transforming Growth Factor-{beta} Signal Modulates Infarct Tissue Dynamics and Attenuates Left Ventricular Remodeling and Heart Failure Circulation, May 17, 2005; 111(19): 2430 - 2437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Getz Thematic review series: The Immune System and Atherogenesis. Immune function in atherogenesis J. Lipid Res., January 1, 2005; 46(1): 1 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. H. O'Neil, M. B. Boffa, M. A. Hancock, J. G. Pickering, and M. L. Koschinsky Stimulation of Vascular Smooth Muscle Cell Proliferation and Migration by Apolipoprotein(a) Is Dependent on Inhibition of Transforming Growth Factor-{beta} Activation and on the Presence of Kringle IV Type 9 J. Biol. Chem., December 31, 2004; 279(53): 55187 - 55195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. K. Hansson, A.-K. L. Robertson, and D. J. Grainger TGF-{beta} in Atherosclerosis Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): e137 - e138. [Full Text] [PDF]
|
|